Top Biotechnology companies in Switzerland by Free Cash Flow Yield

This ranking features the top 22 Biotechnology companies in Switzerland ranked by Free Cash Flow Yield, averaging a Free Cash Flow Yield of -12.19%, for June 28, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Switzerland has the highest Free Cash Flow Yield ?

The Biotechnology company in Switzerland with the highest Free Cash Flow Yield is AC Immune SA (NasdaqGM: ACIU) at 23.45%.
Which Biotechnology company in Switzerland has the lowest Free Cash Flow Yield ?

The Biotechnology company in Switzerland with the lowest Free Cash Flow Yield is Evolva Holding SA (Swiss Stock Exchange: EVE.SW) at None.

What are the top 10 Biotechnology companies in Switzerland by Free Cash Flow Yield ?

The top 10 Biotechnology companies in Switzerland by Free Cash Flow Yield are AC Immune SA, Basilea Pharmaceutica AG, medmix AG, Roche Holding AG, Novartis AG, Tecan Group AG, PolyPeptide Group AG, Sandoz Group AG, Kuros Biosciences AG and Siegfried Holding AG.
What are the bottom 10 Biotechnology companies in Switzerland by Free Cash Flow Yield ?

The bottom 10 Biotechnology companies in Switzerland by Free Cash Flow Yield are Evolva Holding SA, MoonLake Immunotherapeutics, BB Biotech AG, Idorsia Ltd, NLS Pharmaceutics AG, ADC Therapeutics SA, Molecular Partners AG, Santhera Pharmaceuticals Holding AG, CRISPR Therapeutics AG and Oculis Holding AG.